AVMA news
FDA CVM lays out innovation plan for new animal, veterinary products
Leaders with the Food and Drug Administration’s Center for Veterinary Medicine recently outlined the agency’s plan to support the development of safe…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
Use of technology in veterinary medicine
The AVMA supports responsible and ethical development and use of technology that can benefit and protect public health, animal health and welfare, and…
policy
Use of prescription drugs in veterinary medicine
Veterinary prescription drugs are those drugs restricted by federal law to use by or on the order of a licensed veterinarian.
policy
UNDER REVIEWJudicious therapeutic use of antimicrobials in aquatic animal medicine
Aquatic animal veterinarians should use all therapeutants, including antimicrobials, judiciously to restore aquatic animal health, ensure continued…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
FDA issues warnings over CBD for animals
Food and Drug Administration officials warned four companies that they were illegally marketing cannabidiol products for animal use.
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
AASV basic guidelines of judicious therapeutic use of antimicrobials in swine
The American Association of Swine Veterinarians and AVMA both support these guidelines on judicious therapeutic antimicrobial use in pork production.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
AVMA news
Organizations warn against hemp in pet food, livestock feed
Seventeen organizations sent a joint letter that encourages agriculture and state government leaders to wait for results of safety studies before…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
AVMA news
Facing shortage, FDA CVM allows temporary imports of non-FDA approved drug for cattle
A national shortage of an important cattle reproduction drug has prompted the Food and Drug Administration to allow a similar but unapproved product…
AVMA news
FDA warns that topical drug for humans can be deadly to pets
As of September, the Food and Drug Administration had received 14 reports involving 20 dogs that had been accidentally exposed to topical…
AVMA news
Home delivery, autoship important offerings for veterinary clients
A recent survey from Brakke Consulting looked at consumer preferences and behaviors in pet medicine purchasing, customer satisfaction with different…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
AVMA news
USDA awards $3.2M in 2022 to support rural veterinary services
A project at Michigan State University to train veterinary students and practicing veterinarians in honeybee medicine was among 20 recipients of a…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
policy
AAAP guidelines for judicious therapeutic use of antimicrobials in poultry
The AVMA has endorsed these guidelines on judicious therapeutic antimicrobial use in poultry production, developed by the American Association of…